Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) EBITDA Margin (2017 - 2020)

Cogent Biosciences (COGT) has 3 years of EBITDA Margin data on record, last reported at 16020.19% in Q3 2020.

  • For Q3 2020, EBITDA Margin fell 1485127.0% year-over-year to 16020.19%; the TTM value through Jun 2021 reached 28717.31%, down 2862047.0%, while the annual FY2025 figure was 10745.56%, N/A changed from the prior year.
  • EBITDA Margin reached 16020.19% in Q3 2020 per COGT's latest filing, down from 1400.19% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 15.02% in Q4 2019 and bottomed at 16020.19% in Q3 2020.
  • Average EBITDA Margin over 3 years is 1904.33%, with a median of 382.61% recorded in 2019.
  • The widest YoY moves for EBITDA Margin: up 29593bps in 2020, down -1485127bps in 2020.
  • A 3-year view of EBITDA Margin shows it stood at 225.86% in 2018, then soared by 107bps to 15.02% in 2019, then plummeted by -106725bps to 16020.19% in 2020.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 16020.19% in Q3 2020, 1400.19% in Q2 2020, and 86.67% in Q1 2020.